Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Dermik Laboratories
Approval Status: Approved January 1998
Treatment for: Rosacea

General Information

Noritate (metronidazole cream) 1% has been approved as a topical rosacea therapy for the treatment of inflammatory lesions and erythema (facial redness) associated with the condition.

Clinical Results

Noritate has been shown to significantly reduce inflammatory lesions of rosacea in as little as four weeks with minimal skin dryness and irritation.